Owner ID Biomedical Corporation

Inventors Charland, Nathalie; Brodeur, Bernard; Hamel, Josee; Martin, Denis; Ouellet, Catherine

Agent Griffith Hack

Pub. Number AU-B-2001270381

PCT Pub. Number WO01/98334

Priority 60/212,683 20.06.00 US

Filing date 19 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 24 May 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 27/16 (2006.01) Drugs for disorders of the senses

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/315 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione